Abstract
A series of hybrid molecules consisting of benzophenones and N-cyclopropyl-3-methylbenzamides were synthesized and biologically evaluated as novel p38 mitogen activated protein kinase (MAPK) inhibitors. In particular, we found that compound 10g displayed potent p38α MAPK inhibitory activity (IC50 = 0.027 μM), high kinase selectivity, and significant anti-inflammatory activity in THP-1 monocyte cells.
Original language | English |
---|---|
Pages (from-to) | 3694-3698 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 25 |
Issue number | 17 |
DOIs | |
Publication status | Published - 3 Aug 2015 |
Bibliographical note
Publisher Copyright:© 2015 Elsevier Ltd.
Keywords
- Benzophenone
- Hybrid
- Kinase selectivity
- N-Cyclopropylbenzamide
- P38 mitogen activated protein kinase inhibitor